本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

7.18
-0.0500-0.69%
成交量:2.78萬
成交額:20.54萬
市值:4,418.28萬
市盈率:-0.53
高:7.73
開:7.24
低:7.17
收:7.23
52周最高:27.30
52周最低:3.76
股本:615.36萬
流通股本:300.20萬
量比:0.50
換手率:0.92%
股息:- -
股息率:- -
每股收益(TTM):-13.5400
每股收益(LYR):-20.9448
淨資產收益率:-141.82%
總資產收益率:-54.70%
市淨率:0.62
市盈率(LYR):-0.34

資料載入中...

公司資料

公司名字:
Aligos Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2018
員工人數:
70
公司地址:
One Corporate Drive,2nd Floor,South San Francisco,California,United States
郵編:
94080
電話:
傳真:
- -
簡介:
Aligos Therapeutics, Inc.於2018年2月5日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,專註於開發新療法,以解決肝病和病毒感染方面未滿足的醫療需求。

董事

名稱
職位
Lawrence M. Blatt
Chair,President and Chief Executive Officer
Bridget Martell
Director
Carole Nuechterlein
Director
Heather Preston
Director
James Scopa
Director
K. Peter Hirth
Director
Margarita Chavez
Director

股東

名稱
職位
Lawrence M. Blatt
Chair,President and Chief Executive Officer
Lesley Ann Calhoun
Executive Vice President,Chief Operating Officer and Chief Financial Officer
Hardean E. Achneck
Executive Vice President and Chief Medical Officer
Julian A. Symons
Executive Vice President and Chief Scientific Officer
Nikhil Aneja
Principal Accounting Officer